Is it safe to use smoking cessation therapeutics during pregnancy?
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Worldwide, 10 to 35% of pregnant women smoke. It is clear that smoking cessation has positive impacts for both the mother and child, yet many women are still unable to quit due to the addictive properties of nicotine. There are limited data surrounding their safety and efficacy in pregnancy. AREAS COVERED: This review highlights evidence from clinical studies and animal experiments regarding the effects of smoking cessation therapeutics on pregnancy, neonatal and long-term postnatal outcomes. EXPERT OPINION: There are insufficient data at this time to recommend the use of varenicline and/or bupropion for smoking cessation during pregnancy. In addition, the efficacy and safety of nicotine replacement therapy use for smoking cessation in pregnant women has not been clearly demonstrated. Until further studies are completed, there will continue to be considerable uncertainty regarding the use of these drugs in pregnancy despite the well-documented benefits of smoking cessation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cnattingius, S. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001669187 · Cited by 1,126 · cited 1×
“3 Metabolism Cigarette smoking during pregnancy increases the risk of delivering a baby preterm and small for gestational age [71], both of which are associated with an increased incidence of adverse metabolic outcomes, including glucose intolerance, insulin resistance and obesity [72].”
BackgroundPsychosocial interventions for supporting women to stop smoking in pregnancy
Chamberlain, C., O'Mara-Eves, A., Porter, J., Coleman, T., Perlen, S. M., Thomas, J., & McKenzie, J. E. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub5 · Cited by 650
Weng, S. F., Redsell, S. A., Swift, J. A., Yang, M., & Glazebrook, C. P. (2012) · Archives of Disease in Childhood · doi:10.1136/archdischild-2012-302263 · Cited by 592 · cited 1×
“While a recent metaanalysis of 30 prospective studies suggest that babies born to smoking mothers have a 47% increase in the odds of becoming overweight [73], the association between the use of NRT during pregnancy and metabolic abnormalities in the offspring is not yet known.”
BackgroundThe dynamic effects of nicotine on the developing brain
Dwyer, J. B., McQuown, S. C., & Leslie, F. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.003 · Cited by 559
Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558
Bupropion is a nicotinic antagonist
Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509
Luck, W., Nau, H., Hansen, R., & Steldinger, R. (2017) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457063 · Cited by 444
Use of antidepressant medications during pregnancy: a multisite study
Andrade, S. E., Raebel, M. A., Brown, J., Lane, K., Livingston, J., Boudreau, D., Rolnick, S. J., Roblin, D., Smith, D. H., Willy, M. E., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.036 · Cited by 403
Pineles, B. L., Park, E., & Samet, J. M. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwt334 · Cited by 387 · cited 1×
“There is compelling evidence that cigarette smoking during pregnancy is associated with a number of adverse obstetrical and neonatal outcomes including an increased risk of miscarriage, placenta previa, placental abruption, preterm birth, stillbirth, low birth weight, intrauterine growth restriction and sudden infant…”
BackgroundEvidence for altered placental blood flow and vascularity in compromised pregnancies
Reynolds, L. P., Caton, J. S., Redmer, D. A., Grazul‐Bilska, A. T., Vonnahme, K. A., Borowicz, P. P., Luther, J. S., Wallace, J. M., Wu, G., & Spencer, T. E. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.104430 · Cited by 358
Cited by
Success of smoking cessation interventions during pregnancy.
Bérard, A., Zhao, J.-P., & Sheehy, O. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.06.059 · Cited by 51
The effects of electronic cigarette vapor on placental trophoblast cell function
Raez-Villanueva, S., Ma, C., Kleiboer, S., & Holloway, A. C. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.07.084 · Cited by 30
Self-citationWilson, S. M., Newins, A. R., Medenblik, A. M., Kimbrel, N. A., Dedert, E. A., Hicks, T. A., Neal, L. C., Beckham, J. C., & Calhoun, P. S. (2018) · Women's Health Issues · doi:10.1016/j.whi.2018.05.002 · Cited by 20
Nicotine replacement therapy during pregnancy and child health outcomes: a systematic review
Blanc, J., Tosello, B., Ekblad, M. O., Berlin, I., & Netter, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084004 · Cited by 20
Metadata
- Authors
- De Long, N. E., Barra, N. G., Hardy, D. B., & Holloway, A. C.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa UK Limited
- Published
- 2014-10-21
- Volume
- 13
- Issue
- 12
- Pages
- 1721-1731
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2063320747
- Cited by
- 23
- References
- 28
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is it safe to use smoking cessation therapeutics during pregnancy? https://app.cochat.ai/papers/10.1517/14740338.2014.973846
- The paper
- De Long, N. E., Barra, N. G., Hardy, D. B., & Holloway, A. C. (2014). Is it safe to use smoking cessation therapeutics during pregnancy? Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.2014.973846
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.